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Abstract
Looking at the atomic level of biological activity, the electron spin may be considered 
a key parameter, governing fundamental biological processes. Spin states have a major 
role in defining the structure, reactivity, magnetic and spectroscopic properties of a mol-
ecule. In the last decades, there has been a growing interest in the use of magnetic fields 
(MF) to study their influence on different biological systems, considering their effect on 
electron spin energy levels and consequently on redox-related cellular changes. Different 
authors have studied the use of magnetic fields as potential antitumor agent as well as 
an adjuvant agent to chemotherapy and radiotherapy with promising results. Overall, 
the published data support the presence, in laboratory animals, of antitumor efficacy in 
many types of cancer including adenocarcinoma, breast cancer, melanoma and neuro-
blastoma. Those antitumor effects seem to be associated with no observable side effects 
or toxicity in animals or in humans. More studies are necessary, mainly at the clinical 
level, to understand the real potential of this atomic approach in improving availability 
of cancer therapy. In addition, this approach may contribute to fulfill a knowledge gap 
facing biomedical science today, the one between the atomic level and the cellular level.
Keywords: magnetic fields, quantum biology, free radicals, cancer treatment, apoptosis, 
atomic biology, spin state in biological systems, antitumor effects,  
electromagnetic fields, biological effects, electron spin, p53
1. Introduction
Only 25 years ago, at the beginning of the 1990s, chemical biology was just an idea. Since then, 
that idea evolved into a global community of scientists, dedicated to understanding science 
at the interactions of chemistry and biology. The work of this community has greatly contrib-
uted to the development of medical science.
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the t rms of the Crea ive
Comm ns Attribution Lic nse (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Among these studies, the molecular studies (molecular biology branch) have traditionally 
played a very important role in chemical biology research. From a panel of experts, the Nature 
Chemical Biology editors [1], the need for covering the remaining greatest knowledge gap fac-
ing biology today has been underlined: the one between the atomic level and the cellular level.
In fact, since molecules are made of atoms, the new frontier should be to study the influence of 
atomic structure on biological activity. This may be considered a natural evolution of medical 
science development. This development has made impressive progresses through centuries, 
moving from considering humans as an entire entity to considering organ system, organ, cell, 
cell components and, nowadays, molecules (molecular biology). In this trend, the missing 
additional part is the atom, and as a consequence, this new branch of medicine should be 
based on what we could call “atomic biology” (Figure 1).
This opens a fascinating scientific adventure: we strongly believe that Physics has to play an 
important role for the reasons better explained below. The development of a new branch of 
medical science that, in analogy with Chemical Biology, we can call Physical Biology, can 
have the main objective to study the influence of atomic structure on the characteristics of 
the biochemical reactions influencing cell life. A most important contribution is requested to 
elucidate phenomena at the base of biomolecular activity, influencing the genetic pathways 
that regulate cell life in genetically based illnesses, like cancer.
For this typology of illnesses, in fact, Chemical Biology and its branch Molecular Biology 
have been unable to help Medicine to obtain completely satisfactory therapeutic results. More 
selective treatments to avoid important adverse effects are needed.
Figure 1. Trend of medical science from its beginning to now. With time (see from right to left), medicine has been 
developing considering first humans as unity and then made by organs, tissues, cells, until arriving to the present time 
of molecular biology. Since molecules are made of atoms, the next frontier should be the connection between atomic and 
biological levels.
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The fundamental laws of physics have the capability of describing the very tiny processes 
that are at the core of life in matter. Because of this, we know for example that using magnetic 
fields with specific characteristics we can influence spin energy levels. This, for example, gives 
the possibility to medical doctors to use magnetic resonance imaging to have a very power-
ful clue of what happens at molecular/atomic levels of the biological structure and function, 
having consequently the possibility of making diagnosis with an accuracy not possible before.
We know from chemistry that electron spin state has a pivotal role in all the reduction-oxida-
tion reactions that are at the core of the cellular metabolic pathway, governing the behavior of 
the biological system, influencing genetic stability. The synthesis of many complex molecules 
often requires the oxidation of their precursor, via the use of molecular oxygen. Availability of 
electrons to transfer changes when electron spins assume specific energy levels. These energy 
levels are known from quantum physics to be easily influenced by magnetic fields. Physics 
allows the use of specific static magnetic fields like those used in magnetic resonance imag-
ing, but almost two/three order of magnitude (100–1000 times) less intense, not thermal, to 
influence electron spin state.
Aim of this chapter is to analyze the scientific reasons why a more physics standpoint 
approach to biological processes, or in other words an atomic-level-based approach to bio-
logical processes, may contribute to cancer therapy. We will consider biological processes 
from an atomic-level prospective, analyzing first the correlation between the atomic structure, 
its influence on availability of electrons, and key biological functions connected to cancer 
genetics and consequently the available literature reporting results obtained in different labo-
ratories on the use of magnetic fields to influence cancer biology.
2. Atomic structure and fundamental role played by electron spin  
in key biological processes
Considering the three particles (electron, proton and neutron) constituting the atomic structure, 
the electron is the only elementary particle and it plays a pivotal role in chemical/biochemical 
reactions. Electron exchange allows chemical reactions to take place and electron transfer reac-
tions are critical steps in diverse arrays of biological transformations, ranging from photosyn-
thesis to aerobic respiration. Electrons are classified inside all the elementary particles according 
to their spin value that, being half integer, collocate them inside one of the two families of ele-
mentary particles, the fermions [2]. So, the spin has a fundamental role in the nature of matter’s 
structure. Spin is an intrinsic property (form of angular momentum) of particles connected to 
their behavior in the presence of magnetic fields, where they seem to act as small magnets. In 
classical physics, a charged spinning object has magnetic properties that are very much like 
those exhibited by these elementary particles (Figure 2). Similarly, physics describes elementary 
particles in terms of their “spin.” Despite this, spin is a purely quantum-mechanical phenom-
enon; it does not have a counterpart in classical mechanics and obeys quantum physics laws.
Fermions and then electrons obey the Pauli exclusion principle, which states that two identi-
cal electrons cannot exist in the same state, that is, electrons paired in the atomic structure in 
a way to have opposite spin value. Without Pauli exclusion principle, chemistry would not 
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have the Periodic Table. For these reasons, spin is an essential property influencing the order 
of electrons and nuclei in atoms and molecules, thus having great physical significance in 
chemistry. Therefore, we may consider the spin a very important physical entity when study-
ing biomolecular processes. The spin, although being purely quantum-physical, has profound 
implications for real-world, large-scale systems like, for example, living tissue. In most cases, 
according to Pauli principle, electrons need to pair up to allow the system, to which they 
belong, to reach a lower level of energy. This process of electron pairing up facilitates stabil-
ity in the system (i.e., chemical stability in a biological environment), but it is possible only 
when, as above states, electron spins have opposite values. This favorable situation depends 
on the electron origin as well as on the conditions of the chemical environment. When the 
electron pairing up is not possible, the system accumulates an excess of unpaired electrons. 
This process leads to the formation of different spin states of individual electrons as well as of 
molecular species containing unpaired electrons.
Chemically, any molecule containing a single, unpaired electron is defined as free radical. 
Free radicals are often highly unstable elements which in fact are chemically highly reactive 
(Figure 3). In many cases, the spin state has been found to be a key factor governing the behav-
ior of the biological system since their influence in chemistry and bioinorganic chemistry [3].
The spin state has a pivotal role in all the reduction-oxidation (or redox) reactions that are at 
the core of our metabolic machinery. Redox reactions involve the transfer of electrons from 
one reactant to another. This kind of reactions is so important that our life depends on them. 
The synthesis of many complex molecules often requires the oxidation of their precursor, via 
the use of molecular oxygen. The utilization of molecular oxygen is vital in many biological 
Figure 2. Electron while traveling around nuclei or between atoms/molecule rotates about its axis producing a magnetic 
field (from physics in fact we know that any moving charge produces a magnetic field) called angular momentum or 
spin. The electron spin value is ±½ depending on the direction of its rotation.
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pathways. The ability of aerobic organisms to harness the power of molecular oxygen as a 
terminal electron acceptor in their respiratory cycles has revolutionized the evolution of life. 
Oxygen itself is a diradical: Oxygen-based radicals are also often referred to as radical reactive 
oxygen species (ROS), such as superoxide anion (O2−) and hydroxyl radical (OH.). Electrons 
constituting molecules generally have opposite spins. These electrons stay in different orbitals 
and may take part to the bond formation. A peculiar characteristic of the oxygen structure is 
that it has two electrons that are not spin-paired, lying in different orbitals, and each of them 
is looking for an additional electron to pair up. In this case, the process of electron pairing-up, 
making two pair per atoms or four pairs per molecule, is oriented to produce water molecules 
to reach a state of lower free energy. Redox reactions are facilitated by enzymes since they 
have binding sites that can keep oxygen in contact with oxidizable substrates for a long time. 
This contact time, longer than that made possible only by collision, substantially improves 
the chance of spin reversal and allows the two electrons to pair up, process that otherwise 
would be not possible due to limited energy, below the kinetic barrier that would be provided 
by only collisions. Another important aspect is that enzymes may have such characteristics 
to catch and withhold available energy from oxidation processes, activity very useful and 
important in ATP high-energy-related compounds. In addition to this, we know that redox 
reactions affect signaling between molecules bound to DNA with potentially key effect on 
cell cycle. It has been shown that oxidative stress conditions may control the very important 
tumor suppressor protein p53 activity on different promoters using DNA-mediated electron 
transport [4–6]. One of the most challenging endeavors from both experimental and theoreti-
cal point-of-view is to elucidate the role and effect of different spin states on the properties of a 
biological system, even deciding which spin-state occurs naturally. There is in fact a  growing 
interest in spin states in biochemistry from a chemical standpoint [3]. It can be supposed that 
a more physics-dependent approach may contribute significantly to this elucidation. In fact, 
being the spin a purely physical entity (localized magnetic moment/field), its energy states 
Figure 3. Atoms that do have an unpaired electron, like the atom here presented with atomic number of 7 (nitrogen), are 
called free radical. Because of their uncoupled spin, they have a not nulled magnetic moment and, in agreement with 
Pauli principle, they look for a counterpart to reach physical/chemical stability. For these reasons, free radicals are highly 
chemically reactive.
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can be theoretically better influenced by physical means than by chemical reactions. In fact, 
starting from the 1980s, magnetic fields have been widely used to influence the free radical 
chemistry, thanks to their influence on electron spin state energy levels [7].
3. Redox balance and metabolic processes in cancer
The maintenance of redox balance is considered a key factor for the cancer cell metabolism 
[8–11]. Adaption requires for these cells to be able to respond to the proliferative signals that 
are delivered by oncogenic signaling pathways. After malignant transformation, many cancer 
cells show a sustained increase in intrinsic generation of ROS which maintains the oncogenic 
phenotype and drives tumor progression throughout chemical reactions that are electron spin 
state dependent. Redox adaption through upregulation of antiapoptotic and antioxidant mole-
cules allows cancer cells to promote survival and to develop resistance to anticancer drugs [12].
The dependence of tumor cells and cancer stem cells on their antioxidant capacity makes 
them vulnerable to agents that dampen antioxidant systems. There is a realistic prospect for 
treatments aimed to dramatically increase intracellular ROS to kill cancer cells by decreasing 
their antioxidant capacity. This may be obtained using compounds that inhibit antioxidant 
systems or through inhibition of specific signaling pathways that upregulate antioxidants 
in cancer cells. The resulting increase in reactive oxygen species may then induce tumor cell 
death either through random damaging functions of ROS or by specific induction of apopto-
sis via death signaling pathways. The advantage of such a strategy is that normal cells are not 
significantly affected since they have lower basal ROS levels and therefore are less dependent 
on up−/downregulation of oxidative stress [13]. A supposedly more simpler strategy would 
be to selectively influence the ROS concentration and then redox activity in cancer cell by 
directly influencing the spin state energy levels by using appropriate magnetic fields.
It is important to note that dealing with ROS concentration we have to consider the dou-
ble-edge sword of ROS action. In fact, for example, a chemopreventive and an antitumor 
action have been reported by the use of nutraceuticals derived from fruits, vegetables, spices, 
and other natural products used in traditional medicine that show antioxidant efficacy. This 
lasts in agreement with observations [14, 15], suggesting that antioxidant enzymes like the 
mitochondrial antioxidant manganese superoxide dismutase (MnSOD) may function as new 
type of tumor-suppressor gene. The above suggest both “upside” (cancer-suppressing) and 
“downside” (cancer-promoting) actions of the ROS. Thus, similar to tumor necrosis factor-α, 
inflammation, and NF-κB, ROS act as a double-edged sword.
4. How magnetic fields can influence biological chemistry through 
spin state
The fascinating aspect of spin states is that the formation of spin-correlated radical pair 
states between enzyme and oxygen radicals is magnetic field sensitive. In fact, the use of 
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appropriate magnetic fields is capable of changing the spin states of radical pairs modifying 
the rate of conversion between singlet (S) and triplet (T) and consequently influencing the 
free radical recombination rate and finally their concentration with downstream biological 
consequences [16].
Let us now see more in detail the mechanism through which magnetic fields influence spin 
states and consequently free radical chemistry. Radical pairs are typically formed by electron 
transfer or photolytic bond cleavage from a molecular precursor. The radical characteristics 
and then their chemical reactivity depend on their spin states of their unpaired electrons that, 
like all electrons, present an intrinsic spin angular momentum (quantum number s = ½) char-
acterized by two states, known as spin up and spin down. These two states are labeled by the 
magnetic quantum numbers ms = ±½ (ms specifies the projection of the spin angular momen-
tum on a fixed axis). Spin-correlated radical pairs are generated according to the physical 
law that implies the conservation of total spin angular momentum, a singlet molecular pre-
cursor leads to a singlet born radical pair, while a triplet precursor leads to a triplet born 
radical pair. The correspondent two spins of the born radicals will be aligned antiparallel 
and parallel for the singled and triplet born, respectively. S0 is generally used for the singlet 
state, its total spin quantum number S is zero as well as its overall spin angular momentum, 
so their energy is independent of any applied magnetic fields. Vice versa, the three triplet 
states T0, T+ and T− are defined by a total spin S = 1 and spin projection numbers equal to 0, +1 and −1, respectively. In the presence of an applied static magnetic field, the energy of the T0 state is therefore also field independent, whereas how the energies of the T
+
 and T− states are 
shifted by the Zeeman interaction is proportional to the strength of the external applied static 
magnetic field (Figure 4). In the absence of an external static magnetic field, interconversion 
between the singlet and triplet states of the radical pair is driven by internal electron-nuclear 
hyperfine interactions.
The use of an external static magnetic field influences the interconversion between singlet 
and triplet states (see circle in Figure 4), influencing the rate of recombination of radical pair 
and consequently influencing free radical concentration. Even if the energy released by the 
magnetic field to the electron spin is significantly less than the thermal energy, the interesting 
aspect is that the spin-correlated radical pair, being in a nonequilibrium state, allows a kinetic 
effect if subsequent radical reactions are spin selective.
The frequency, amplitude and orientation of the magnetic field that perturbs the radical pair 
dynamics depend significantly on the local enzymatic chemical environment [17]. Specifically, 
the use of magnetic fields of moderate intensity (milli Tesla, or mT, range), static and/or at 
extremely low frequency, (frequency up to 300 Hz, down to 3.3 milliseconds) acts through 
the Zeeman effect removing the degenerative triplet energy levels. Considering the very short 
life span of a free radical (from microseconds to nanoseconds), it sees the extremely low-
frequency magnetic fields as static, which intensity is time dependent.
It results, as discussed above, in the splitting of three levels of different energies, decreasing 
the probability of transaction from triplet to singlet spin states. The rate of free radical recom-
bination, at a frequency from low to zero, depends on the intensity of magnetic fields that 
regulates the conversion from triplet to singlet state (Figure 4 crossing between T− and S0).
Role of an Atomic-Level-Based Approach for Improving Cancer Therapy
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Magnetic fields at much higher frequency (a mega Hz, or MHz, order of magnitude) used 
in combination with static magnetic fields can also have importance in influencing the spin 
states and then the correspondent chemical reactions. There are in fact multiple interactions 
in which weak magnetic fields (intensity on the order micro Tesla, or μT) at higher frequency 
can change the population distribution in the various spin states, among them the electron-
nuclear hyperfine interaction. External static in combination with high frequency magnetic 
fields can alter radical pair spin dynamics by Zeeman and HFI resonance effects and thereby 
change the relative yields of reaction products that derive, alternatively, from singlet and trip-
let radical pair states [18–20]. Many biological molecules exhibit hyperfine splitting constant 
that ranges from 0.1 to 35 MHz [20–22], so fields of this frequency may be used to influence 
hyperfine coupling resonance. Magnetic fields at this higher frequency and very low inten-
sity have been used, together with static magnetic fields, to influence hyperfine resonance, 
decreasing the intracellular superoxide concentration to selectively increase rat pulmonary 
arterial smooth muscle cell proliferation [23].
One can then suppose that appropriate magnetic fields may be used to perturb spin energy 
levels influencing the singlet-triplet and vice versa transaction probability and therefore con-
trolling specific biochemical reactions and metabolic pathways. Different experimental data 
support the above hypothesis that magnetic fields, mainly static and extremely low-frequency 
fields, influence the ROS chemistry. This hypothesis is in agreement with the conclusion of a 
survey conducted, considering 41 scientific original publications showing that the use of this 
type of fields is capable of influencing the ROS chemistry in biology [24].
In addition, data coming from one multiannual, multicenter, multidisciplinary cancer research 
project have been reviewed [25]. In this project, static and extremely low-frequency magnetic 
fields having intensity on the mT range were used to influence electron spin energy levels and 
Figure 4. Effect of the Zeeman splitting on the singlet (S0) and triplet (T0, T+ and T−) states. As we can see, increasing magnetic field intensity, the degenerative energy levels of triplet separate to reach a value (circle) at which we observe 
the crossing between T− and S0.
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consequently ROS chemistry and related redox cellular signals showing promising results. 
In fact, important anticancer effects have been reported in vitro as well as in vivo through an 
influence on the genetic pathway that increases apoptosis via the p53 protein with no adverse 
effects in different human cancer models.
5. Magnetic fields as a new potential effective antitumor agent acting 
through the electron spin
In the last decades, there has been a growing interest in the use of magnetic fields, in studying 
their influence on different biological systems, considering their effect on electron spin energy 
levels and consequently on redox-related cellular changes and on genetic instability [25].
Different authors have studied the use of static and extremely low-frequency magnetic fields 
as a potential antitumor agent as well as an adjuvant agent to chemotherapy and radiother-
apy with promising results. Overall, the published data support the presence of antitumor 
efficacy in many types of cancers including adenocarcinoma, breast cancer, melanoma and 
neuroblastoma.
Different Italian Health Institutions and Universities have realized the importance of this poten-
tial new approach to cancer treatment by starting, years ago, a multiannual, multidisciplinary, 
multicenter research project, conducted, for the laboratory part, mainly in a GLP-certified labo-
ratory. The project aim was to validate the hypothesis that an atomic-level-based approach to 
biological processes may help to improve cancer therapy. The project has produced a variety 
of results published in different Journals. Later, the research activity, which can be considered 
a continuation of the project, restarted in the Medical School of a Chinese University.
Different from other projects, the considered one provides an entire set of data obtained from 
a series of multiple in vitro and in vivo laboratory trials, as well as a pilot study conducted 
on humans. Project carried out with this logic have yielded a corpus of data, organized and 
linked together in a logical fashion to allow organic and more complete, articulated analysis 
than with those coming from a single study. These characteristics are even more important in 
the fields of bioelectromagnetisms, where different authors have been using different mag-
netic fields and different biological means, providing a huge set of data difficult to correlate 
and then to interpret. These are the reasons why in analyzing the published data, supporting 
the efficacy of magnetic fields to induce antitumor effects, in agreement with the hypothesis 
that an atomic-level-based approach to biological processes may contribute to improve cancer 
therapy, we start with those coming from the above-cited project. Analysis of data coming 
from other project will follow (see the paragraph “Scientific consensus on the anticancer effi-
cacy of magnetic fields”).
5.1. Connecting atomic structure to biological activity
The multicenter project first objective was to find a connection between the fundamental law 
regulating the structure of matter and key biological function(s) regulating the stability of 
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genetic machinery and the conservation of the species. First the atomic structure was ana-
lyzed, realizing that the key parameter governing the formation of matter as well as its stabil-
ity is the (electron) spin state as above reported.
In fact, let us consider the biological processes at the base of our life. The human body is con-
stituted by almost 37,000 billion cells, and as an average, billion cells replicate every day; for 
each replica, almost a thousand billion of DNA bases replicate for every cell division. These 
incredible numbers tell us how complex and at the same time fascinating is the biological life 
as we know it. Which incredible organization Nature has set up to avoid as much as possible 
diseases due to the inevitable mistake during such huge number of copies of DNA basis. This 
organization allows that most of these errors will remain silent, but also minor errors can have 
a serious impact. In addition, despite its essential role in storing genetic information, the DNA 
molecule has limited chemical stability and is subject to spontaneous decay [26].
Processes such as hydrolysis and oxidation occur at significant levels in vivo, in part due to 
reactive metabolites continuously generated in various physiological processes. In addition, 
external factors like radiation and genotoxic chemicals will further stimulate DNA damage 
formation. The inherent instability of DNA constitutes both an opportunity and a threat. 
DNA lesions can block important cellular processes such as DNA replication and transcrip-
tion, cause genome instability and impair gene expression. Lesions can also be mutagenic 
and change the coding capacity of the genome, which can lead to devastating diseases and 
conditions associated with genome instability, including cancer, neurodegenerative disorders 
and biological aging. At the same time, without mutations, Darwinian evolution would not 
be possible.
Cells use different biological processes like DNA repair, apoptosis and others like autophagy 
working in a well-defined and coordinated manner to contrast genome instability and pre-
vent much as possible the onset of serious diseases.
Analyzing these processes, apoptosis appeared the most interesting one to be connected with 
the key physical parameter governing the stability of matter, that is, electron spin. In fact, 
apoptosis is the process set by cells to control genetic machinery in order to avoid replication 
of cell having an altered DNA. Thousands of proteins take part in a well-organized manner 
into this process that will send to death the cell with altered DNA before replication. In case 
of cancer, among thousands of proteins, the p53 protein, called the “DNA guardian,” seems 
to have a key role since, in mutated form, it is present in most cases of human cancers. This 
protein is considered so important that its encoding genes taken together are the most studied 
protein and genes in literature, with a total of more than 80,000 entries in PubMed [27].
5.2. Magnetic field characteristics, cell culture results and tumor growth inhibition
As seen before, different papers relate to p53 activity with redox machinery and ROS forma-
tion [4–6]. Accordingly, an intriguing hypothesis is to consider the possibility of selectively 
affected tumor cell growth using appropriate magnetic fields such as to influence redox sig-
naling via an effect on electron spin state energy levels of ROS/enzymes that are connected 
with p53 activity/status (scheme of Figure 5) [28].
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According to the above-reported effect on the influence of magnetic fields on electron spin 
state, characteristics of the fields that are more suitable to influence cancer cell redox activity 
and p53-dependent apoptosis should result in agreement with known theory [7, 16, 28–30]. A 
series of about 100 in vitro trials exposing three different cell lines (MCF-7 human breast adeno-
carcinoma, WiDr human colon adenocarcinoma and MRC-5 human embryonal lung fibroblast) 
have been performed and apoptosis as a function of magnetic field exposure characteristics 
(intensity and frequency) has been assessed [31]. The magnetic field characteristics that gave 
best results were constituted by a combination of static and extremely low frequency, to form 
an extremely low-frequency modulated static magnetic field with intensity varying between 1 
and 8 mT, as shown in Figure 6. The total time average intensity of this magnetic field was 5.5 
mT. The characteristics of this field, experimentally selected, were in agreement with what was 
predicted by theory. The efficacy of this field has been confirmed in an animal trial exposing 
different group of nude mice bearing a WiDr human colon adenocarcinoma, each group with 
different magnetic field exposure regime, assessing tumor growth inhibition and apoptosis [31].
The in vitro results, obtained using different magnetic field frequency as well as intensity, 
show that magnetic fields are able to induce apoptosis like death, only in the considered 
Figure 5. Biophysical model used to produce antitumor effects. Magnetic fields’ effect on free radical recombination rate, 
activating redox signaling that influence mutant p53 activity and inhibit tumor growth via apoptosis.
Figure 6. Magnetic field treatment characteristics. The magnetic fields were obtained with superimposition of a static 
magnetic field with an alternating 50-Hz (0.02 s) magnetic field forming an intensity-modulated magnetic fields which 
total intensity ranges from 1 to 8 mT with a time total average of 5.5 mT. The total treatment time for daily session is 
70 min.
Role of an Atomic-Level-Based Approach for Improving Cancer Therapy
http://dx.doi.org/10.5772/intechopen.72324
13
tumor cells, when their intensity is higher than 1 mT and this does not depend upon mag-
netic field frequency in the studied frequency range (0–300 Hz). This suggested to the 
authors that, in agreement with the theory at the base of the entire project, the biophysi-
cal mechanism connected to the apoptosis like death induction may be more related to 
free radical recombination processes than to ion resonance like mechanisms. Free radical 
recombination processes are activated by a direct action of magnetic fields on electron spin 
energy state levels of atoms and molecules with unpaired electrons. It was in fact known 
that free radical recombination processes occur in a timescale of nanoseconds to microsec-
onds, and in this timescale, the extremely low-frequency (0–300 Hz) magnetic fields are 
seen as static [32, 33]. In addition, the authors noted that the need for amplitude-modulated 
fields (the one that gave the best tumor growth inhibition) to increase the effect otherwise 
obtained using only static or extremely low-frequency magnetic fields observed in vitro 
and in vivo [31] is in agreement with the need for establishing optimal condition(s) for the 
singlet-triplet spin state conversion required for the free radical recombination processes 
[34]. Safety analysis, in agreement with the theoretical biophysical mechanism, shows no 
toxic morphological changes induced by the magnetic field exposure in renewing, slowly 
proliferating, or static normal cells.
Treatment time may exert also an important role: a 70 min per day treatment for 5 days a week 
for 4 weeks has shown an inhibition of tumor growth of about 50%. The same 70-min treat-
ment used two times a day gave a tumor growth inhibition of almost 70%, suggesting that 
in analogy with a chemical treatment this type of physical treatment exerts a form of dose-
response efficacy, considering the time treatment connected to dose response.
5.3. Survival, apoptosis and p53 studies
In another animal trial using the same tumor model, nude mice were exposed, once a day, 
5 days a week for the entire life to study survival, tumor growth inhibition and immune-reactive 
p53 [35]. After almost 1 year of treatment, the treated mice improved significantly their life span 
and the correspondent Survival Index was 1.31, that is, 31% survival time increase (Figure 7).
Specimens from each experimental mouse (magnetic fields exposed and not magnetic fields 
exposed) after weighted underwent histopathology, immunohistochemistry and transmis-
sion electron microscopy analysis. The results show that exposure to magnetic fields inhibits 
tumor growth of mice bearing a subcutaneous WiDr human colon adenocarcinoma, in agree-
ment with the previous study. In addition, significant variation (by about 50%) in mitotic 
index (decrease), apoptosis (increase) and mutant p53 protein (decrease) (Figure 8) in tumor 
tissue is analyzed at the end of exposure time.
The observed tumor growth inhibition appears to be associated with morphological changes 
only in transformed cells. No morphological changes in renewing (i.e., bone marrow cells), 
slowly proliferating (i.e., hepatocytes) and static (i.e., terminally differentiated neurons) nor-
mal cells were observed. In addition, no significant differences in the number and morphology 
of blood corpuscular elements, emunctory function of liver and kidney, and bone metabo-
lism were detected, between the exposed and not-exposed animals. Authors’ comments were 
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that the lack of adverse responses in normal cells and tissues suggests that the safety of this 
 physical treatment may be related to its ability to interfere preferentially selectively with 
transformed cells. About p53 results they commented that from literature it is known that a 
loss of p53 functional status, due to either lack of gene expression or overexpression of its 
mutant form, leads to genomic instability and cancer [36]. The most frequently encountered 
mutations of p53 reduce its thermodynamic stability, determining the loss of the DNA bind-
ing conformation indispensable to the transcription regulation and tumor suppressor activity 
[37]. Pharmacological rescue of mutant p53 conformation and function has been also reported 
[38]. Others demonstrated that metal ions play a regulatory role in the control of p53 fold-
ing and DNA binding activity [39]. Specific DNA binding is influenced by redox regulation 
of p53, and binding of metal ions may directly affect p53 redox potential, either at the zinc 
binding cysteine residues or at other cysteine residue on the protein surface [40]. Thus, based 
on these data, authors suggest that the observed decrease of mutant p53 after magnetic field 
exposure, together with the increased apoptotic index and the slower growth of experimental 
tumors, could be explained by a rescue of wild-type p53. This phenomenon could be related 
to the effect of magnetic field exposure redox chemistry connected with metal ions.
5.4. Inhibition of metastatic spread and growth
Another important parameter to be evaluated in the assessment of potential antitumor efficacy 
of a treatment is its capability to inhibit the metastatic process. For this reason, a subsequent 
animal trial was conducted to evaluate the influence of the magnetic field treatment in the inhi-
bition of metastatic spread and growth in a breast cancer model [41]. More specifically, a highly 
metastatic (in the lung) human cancer (MDA-MB-435) model, transplanted in nude mice, was 
used. Mice were exposed at the same magnetic field treatment regime (70 min a day for 5 days a 
Figure 7. Survival time (days) of nude mice bearing human adenocarcinoma cancer and magnetic field treated (continue 
line) versus survival time (days) of nude mice bearing human tumor and not magnetic fields treated (dotted line). The 
magnetic field increases significantly the life span of nude mice bearing human cancer.
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week) for 6 consecutive weeks. To allow a more complete evaluation of the potential antitumor 
efficacy of the magnetic field treatment, a positive control group treated with a chemothera-
peutic agent (cyclophosphamide) was also used. At the end of the experiment, separate sections 
from each lung were examined at the microscope to determine the incidence of the different 
treatments (magnetic fields and cyclophosphamide) on number and sizes of metastases. Lung 
metastases were histologically counted, and each one was scored on the basis of the number 
of tumor cells. The size of each metastasis was evaluated by classifying the metastases in three 
categories (<10, 10–100, and >100) according to the total number of cells contained. As shown 
in Figure 9, both magnetic fields and cyclophosphamide treatments significantly decreased the 
number of lung metastases, classified according to the number of cell contained. In addition, 
the magnetic field treatment performed significantly better than cyclophosphamide.
Figure 8. Influence of the magnetic field treatment on mutant p53 concentration (A) that markedly decreases, and on 
apoptosis (B) that markedly increases.
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In fact, while magnetic field treatment and cyclophosphamide-treated mice reported almost 
the same number of metastases in the lowest cell content category (<10 cells), magnetic field-
treated and cyclophosphamide-treated mice in the medium cell-content category (10–100 
cells) reported 98% and 50% reduction in the number of metastases, respectively, while in the 
high cell-content category (>100 cells) was 100% and 90% for the magnetic field treated and 
cyclophosphamide-treated mice, respectively, compared to the control mice. Safety analysis 
was performed in all experimental animals. Results were in agreement with those observed 
in the previous trials confirming the safety of the treatment. In fact, gross pathology at necros-
copy, hematoclinical/hematological, and histological examination did not show any toxic or 
abnormal effects.
5.5. Synergism with chemotherapeutic agent atomic biology
The following trial was conducted to enquire about the possible synergism between magnetic 
field treatment and chemotherapeutic agents in terms of their influence on survival time [42]. 
Two animal models were tested, and immune-competent mice bearing murine Lewis Lung 
Carcinoma (LLCs) or B16 melanotic melanoma were exposed to magnetic fields treated with 
two commonly used anticancer drugs. The chemotherapeutic agents under investigation were 
cis-platin and cyclophosphamide, for the first and second models, respectively. The mice were 
exposed to the same magnetic fields used in the previous trials (static with the superimposi-
tion of extremely low-frequency magnetic field having a total time average intensity of 5.5 
mT), provided daily (7 days a week) for the entire life. Synergistic activity was found only with 
cis-platin. In fact, the cis-platin antitumor efficacy was increased by magnetic field exposure, 
Figure 9. Effect of magnetic field (MF) in spread and growth of lung metastasis in nude mice bearing human metastatic 
breast cancer. Results are compared with those coming from the same experiment where the other group, of the same 
nude mice bearing the same human cancer, was treated with cyclophosphamide, a known chemotherapeutic agent. 
Results, in terms of small-size metastasis (black bars), medium-size metastasis (white bars) and large-size metastasis 
(black and white bars), show that the magnetic field treatment is more efficient than cyclophosphamide in inhibiting 
spread and growth of metastasis.
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leading to significantly prolonged animal survival. The magnetic field treatment almost tri-
pled the efficacy of cis-platin since the effect of cis-platin low dose (3 mg/Kg) used in combina-
tion with magnetic field exposure was similar to that of cis-platin high dose (10 mg/Kg) alone. 
Unfortunately, it is not possible to make a direct comparison between the presence/absence of 
synergism between magnetic fields and the anticancer activity of cis-platin and cyclophospha-
mide because the two drugs were tested on two completely different animal models (different 
mouse strains and tumors). The authors’ comments were that the synergistic activity observed 
between magnetic field exposure and cis-platin can be explained by the hypothesized ability 
to influence free radical chemistry exerted by the magnetic field treatment [28]. Two mecha-
nisms, alone or combined, may be at the base of the observed results. First the platinum ion 
stimulates superoxide radical production [43, 44], and the magnetic field exposure enhances 
active oxygen production. When this production occurs at the cell membranes, the respective 
permeability changes, influencing the cell drug intake [44]. Second, it has been shown that the 
rate of conversion of cis-platin to reactive species, able to bind to DNA, is increased by local-
ized production (in our case possibly due to the magnetic field exposure) of free radicals [45].
5.6. Safety of the treatment and considerations on efficacy
This magnetic fields treatment was then used in a pilot study where, according with the 
authorization of the Ethical Committee instituted by law, patients with advanced neoplasm 
were exposed to magnetic fields to assess safety and acute toxicity [46]. Eleven patients were 
treated with the same magnetic field characteristics we used in animal trials (static with the 
superimposition of extremely low-frequency magnetic field having a total time average inten-
sity of 5–5 mT). Treatment included neck, thoracic and abdomen areas. Two treatment pro-
tocols that differed in the length of daily exposure to magnetic fields were set. In the first, 
patients were treated for 20 min/day, 5 days a week, over 4 weeks; in the second, patients were 
treated for 70 min/day, 5 days/week, over 4 weeks. A minimum of two patients was intro-
duced in each treatment plan; if intolerable toxicity was not observed, two to five additional 
were treated. The reported results show that human exposure to the used magnetic fields 
treatment is not associated with important toxic and adverse side effects. Different expo-
sure regimes, exposing 20–70 min daily, respectively, appear to be associated only to small 
changes in some laboratory parameters. Authors of the study conclude that the overall data of 
this clinical study on safety in humans seem to be in agreement with safety and toxicity data 
from animal trials, showing no toxic or abnormal effects when gross pathology at necroscopy, 
blood and histological examination were performed [28, 31, 35, 41, 42]. In conclusion, the find-
ings of this pilot study carried out in a small number of cancer patients support the possibility 
that the human exposure to magnetic fields with specific physical characteristics is associated 
with a favorable safety profile and good tolerability.
Based on all above-reported laboratory studies, it has been possible to confirm the antitumor 
efficacy of this new physical treatment that uses specific magnetic field characteristics. In 
fact, the reported data confirm the capability by magnetic fields to exert significant antitumor 
effects in different laboratory animal models as well as synergistic activity with chemother-
apy without significant adverse effects. This may support the validity of this new approach 
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to biological processes. More studies are necessary, mainly at the clinical level, to understand 
the real potential of this atomic approach in improving availability of cancer therapy. In addi-
tion, this approach may contribute to fulfill a knowledge gap facing biomedical science today, 
the one between the atomic level and the cellular level.
5.7. Result confirmation
The antitumor efficacy reported in the above illustrated papers was confirmed, years later, in 
a different laboratory, located within the Medical School of the Zhejiang University, China. 
This replica performed in a different laboratory located in a different continent, using the 
same exposure machine as well as the same magnetic field characteristics, gives to the old/
previous project results the necessary scientific validity, scientific validity that is confirmed 
when the same results are reported in different laboratory using the same methodology. In 
this university, the antitumor efficacy of magnetic fields treatment has been studied in two 
pediatric tumors, nephroblastoma and neuroblastoma [47]. The antitumor efficacy exerted 
by this magnetic field treatment as well as its combined effect with cis-platin was studied 
in vitro and in vivo. In this Chinese study, the time-average intensity of the magnetic fields 
was slightly different from the previous studies, 5.1 mT instead of 5.5 mT. This is due to the 
modification of the time duration of each of the eight rounds constituting, as in the old project, 
one magnetic fields treatment session. In the old project, each round lasted different times 
[48]. Now, each round lasted 3.5 min, and consequently each exposure session of treatment 
lasted 28 min. One or more treatment sessions (up to 4) were administered daily. In addition 
to the use of the standard static with the superimposition of extremely low-frequency mag-
netic field having a total time average intensity of 5.1 mT, alternatively, only static magnetic 
fields were used, while the total time-average field intensity was kept to 5.1 mT to help under-
standing the biophysical mechanisms.
For the in vivo part of the study in China, mice magnetic field exposure was based on the 
same exposure system and with the same protocol except that each round lasted 10 min; thus, 
each session lasted 80 min instead of 70 min as in the old project. Mice received one session 
of treatment daily for 15 consecutive days. In vitro results show that after daily exposure 
of 2 h the cell number of nephroblastoma and neuroblastoma cell lines (G401, CHLA255, 
N2a) decreased significantly from day 2, and the inhibition rate reached to about 20% after 
3 days of exposure. The inhibitory effect was positively associated with exposure time, and 
subtraction of the AC field decreased the inhibition rate. Furthermore, it was found that the 
field decreased cell proliferation and induced apoptosis. Combining of the field with chemo-
therapeutic cisplatin further increased the inhibition rate compared with single use of either 
cisplatin or MF. In G401 nephroblastoma tumor model in nude mice, daily exposure of 80 min 
per day combined with cisplatin resulted in significant decrease of the tumor mass. The side 
effect of combinational treatment was limited to mild liver injury (an increase in aminotrans-
ferase levels), while magnetic field exposure did not hamper liver and kidney functions by 
itself. In conclusion, this 50 Hz, static modulated magnetic field exhibited antitumor effect on 
neuroblastoma and nephroblastoma and had the potential to be used in combination with 
cis-platin for increased efficacy and reduced side effects in these two childhood malignancies.
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These results from Zhejiang University are completely in agreement with the previous results 
of the multiannual, multi-disciplinary, multicenter research project, confirming the antitumor 
efficacy of the magnetic field treatment exerted in two new human cancers (nephroblastoma 
and neuroblastoma), its synergistic activity with the studied chemotherapeutic agent cis-
platin, with no induction or trivial induction of adverse effects. This agreement confirms the 
scientific validity of the potential antitumor efficacy of this new physical treatment that uses 
magnetic fields (electromagnetic energy) and that comes from a new approach of biological 
processes based on quantum physics, and such approach considers the atomic structure as a 
key aspect in studying the biological activity possibly introducing to a new additional branch 
of medical science that might be called atomic biology in analogy with molecular biology.
5.8. Scientific consensus on the anticancer efficacy of magnetic fields
There has been a growing scientific consensus on the anticancer activity of static and extremely 
low-frequency magnetic fields. In the last decade, many authors have published different 
papers, reporting results that are in agreement with those analyzed above. We now will shortly 
analyze the content of these papers.
Specifically, tumor growth inhibition has been studied on nude mice bearing metastatic 
mouse breast tumor cells exposed to 100 mT, 1 Hz magnetic fields for different times a day 
(60, 180, and 360 min/day) for 4 weeks, observing a tumor growth inhibition as a function of 
the exposure time reaching the suppression of tumor growth when exposure was 360 min/
day [49]. Tumor growth inhibition as well as metastasis inhibition was observed in mice 
bearing hepatocarcinoma cells exposed to 400 mT, 7.5 Hz magnetic fields, 120 min/day for 
30 days, observing an inhibitory effect on tumor growth [50]. In another study, the applica-
tion of 4.5 mT, 120 Hz magnetic fields, 50 min/day for 32 days inhibited preneoplastic lesions 
chemically induced in the liver of male rats by reducing cell proliferation [51]. The synergistic 
effect with anticancer drugs has been studied in vivo and in vitro by different authors. In vivo, 
El- Bialy et al. [52] studied female mice bearing an ascites carcinoma treated with 3 mg/Kg 
i.p. cis-platin and exposed to 10 mT, 50 Hz magnetic fields 60 min/day for 2 weeks, show-
ing that extremely low-frequency magnetic fields enhanced the cytotoxic activity of cisplatin 
and potentiate the benefit of using a combination of low-dose cisplatin and extremely low-
frequency magnetic fields in the treatment of ascites carcinoma. Chen W.F. et al. [53] studied 
human leukemic cells (K562) exposed in vitro to 8.8 mT static magnetic fields, treated with 
cis-platin at concentrations from 20 to 10 microg/ml, and the results suggest that the mecha-
nism is correlated with the DNA damage model. Hao Q. et al. [54] reported results showing 
that an 8.8 mT static magnetic fields enhanced the cytotoxic potency of adriamycin (25 ng/ml) 
on K562 cells, and a decrease in P-gp expression may be one reason underlying this effect. 
Kakikawa M. et al. [55] reported results showing that 50 mT, 60 Hz magnetic fields enhanced 
the cytotoxicity both of mitomycin C and of cis-platin on E. coli bacterium; these results sug-
gest that magnetic fields change the permeability of the cell membrane and affect drug intake. 
Results of a clinical trial devoted to studying the effects on palliation of general symptoms as 
well as survival were reported by C. Sun et al. [56] in 13 advanced nonsmall cell lung cancer 
(NSCLC) patients treated with 400 mT, 0–50 Hz magnetic fields 120 min/day for 6–10 weeks. 
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The authors observed prolonged survival and moderately improved general symptoms with-
out any severe toxicity or side effects. More recently other three studies have been published 
enlarging the above scenario. Two hours of treatment with 50 Hz, 20 mT magnetic fields 
makes resistant cells of human ovarian carcinoma sensitive to cisplatin via p53 activation [57]. 
A metastatic melanoma mouse model exposed 400 mT, 7.5 Hz magnetic fields, 120 min/day 
for 27 days reported a significant growth inhibition of metastatic tumor burden of lung, show-
ing that extremely low-frequency magnetic field exposure promoted the inhibitory effect of 
ROS on AKT pathway and decreased Foxp3 expression [58]. Three-hour exposure to 1 mT 
50 Hz magnetic fields induces apoptosis on osteosarcoma cells via oxidative stress [59].
Part of the above-cited studies has been also considered in two reviews published in 2013, one 
devoted to analyze if radiotherapy could be enhanced by electromagnetic field treatment [60]. 
The first review concludes that the analyzed studies reflect encouraging results and corrobo-
rate the hypothesis that combined exposure to some chemical agents ionizing radiation should 
be used to increase DNA damage and help cancer treatment. The other review covers three 
areas of investigation connected to the use of magnetic fields, in particular free radical genera-
tion and oxidative stress, apoptosis, genotoxicity and cancer [61], concluding that magnetic 
field causes oxidative stress and, as a result, damages ion channels, leading to changes in cell 
morphology and expression of different genes and proteins and also changes in apoptosis and 
proliferation. In addition, about the use of magnetic fields in combination with other external 
factors, such as ionizing radiation and some chemicals, there is evidence strongly suggest-
ing that magnetic fields modify their effects, improving cancer treatment. Finally, the authors 
stated that the analyzed studies provide valuable insight into the phenomenon of biomagne-
tism and open new avenues for the development of new medical applications. More recently, 
L. Montagnier, the 2008 Nobel Prize for Medicine assignee, has stressed, also on the base of the 
above scientific scenario, the importance of the use of magnetic fields in cancer treatment [62].
6. Comments and conclusions
All the reported reviews conclude that additional studies are necessary to better clarifying 
the biomolecular mechanism(s) and understand the real potential of this new possible medi-
cal treatment. The call for additional studies, included clinical ones, has been also suggested 
by the more recent review dealing with the capability of magnetic fields to influence genetic 
stability and the potentiality of their use in cancer treatment [25]. This last concludes that 
a number of papers reports on the correlation between static and extremely low-frequency 
magnetic fields and genetic instability. This correlation has been found in studies on gene 
expression and DNA damage due to oxidative stress, including double–strand breaks, chro-
mosomal aberrations and micronucleus induction. This review also underlines that the ana-
lyzed literature makes it plausible to apply an atomic-level approach to biological processes 
(atomic biology approach) using electromagnetic energy as a bridge between the atomic level 
(spin energy levels) and the cellular level (oxidative stress, DNA damage, genetic instability, 
p53 status and apoptosis).
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The content of present chapter, together with the consensus among the analyzed literature, sup-
ports the capability by magnetic fields to exert significant antitumor effects in different labora-
tory animal models as well as synergistic activity with chemotherapy. This, without significant 
adverse effects observed in the laboratory animal trials as well as in the limited human studies, 
highlights the potential validity of this new atomic based approach to biological processes.
We are only at the beginning of a scientific adventure of this new potential branch on bio-
logical/medical research that may be called atomic biology. The atomic (electron spin) based 
approach to cancer treatment has given promising results to foresee great potentiality of this 
approach to open new frontiers of biomolecular research and medical application, since mag-
netic fields, different from chemical products, have the capability of influencing in a very 
selective way only the desired spin state of a given biomolecule. The expected clinical results 
for this type of approach would hopefully be more selective, that is, with less adverse effects. 
More studies are necessary, mainly at the clinical level, to understand the real potential of this 
atomic approach in improving availability of cancer therapy.
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